Log in to save to my catalogue

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vac...

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vac...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d77c8ef898934e4e9eef567e35f7d027

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants

About this item

Full title

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-12, Vol.12 (1), p.7288-14, Article 7288

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Identifying risk factors for impaired oral rotavirus vaccine (ORV) efficacy in low-income countries may lead to improvements in vaccine design and delivery. In this prospective cohort study, we measure maternal rotavirus antibodies, environmental enteric dysfunction (EED), and bacterial gut microbiota development among infants receiving two doses o...

Alternative Titles

Full title

Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d77c8ef898934e4e9eef567e35f7d027

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d77c8ef898934e4e9eef567e35f7d027

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-27074-1

How to access this item